Irritation and sensitization potential of novel dissolving microneedle patch : in vivo study

Division of Dermatology, Department of internal medicine, Faculty of medicine, Thammasat University0 个研究点目标入组 28 人开始时间: 2022年1月27日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1. Healthy male or female participants, aged 18-65.
•2. Participants who are willing to join the project after receiving a detailed description of the project and signing a consent form for the study.
•3. Participants can follow the testing method to follow up on treatment results throughout the study period and can report side effects that arise from the study immediately.

•1. Participants who are pregnant, breastfeeding, or planning to become pregnant.
•2. Participants who had history of dermatologic conditions such as atopic dermatitis, psoriasis, vitiligo, melanoma, squamous cell carcinoma.
•3. Participants who had history of Diabetes mellitus, porphyria, primary immunodeficiencies, HIV, anaphylaxis, asthma, generalized drug reaction, lymphoma, leukemia.
•4. Participants had a history of connective tissue disease.
•5. Participants who took immunosuppressants (Immunosuppressive agents).
•6. Participants who had a history of allergic contact dermatitis to Tegaderm.

发起方

Division of Dermatology, Department of internal medicine, Faculty of medicine, Thammasat University